Mc Adam, LLC Clovis Oncology, Inc. Transaction History

Mc Adam, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$4.13 - $6.41 $44,777 - $69,497	-10,842 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $32,245 - $51,646	-6,690 Reduced 38.16%	10,842 $63,000
Q2 2020 Jul 31, 2020	SELL	$5.69 - $9.69 $56,234 - $95,766	-9,883 Reduced 36.05%	17,532 $118,000
Q1 2020 May 08, 2020	BUY	$3.77 - $11.0 $45,918 - $133,980	12,180 Added 79.95%	27,415 $174,000
Q4 2019 Jan 23, 2020	BUY	$3.0 - $16.43 $9,135 - $50,029	3,045 Added 24.98%	15,235 $159,000
Q3 2019 Oct 15, 2019	BUY	$3.93 - $15.35 $47,906 - $187,116	12,190 New	12,190 $48,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.